πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 65 of 200 Β· A–Z by INN

  1. emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype)

    EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN"

    PMDA: approved

  2. enalapril

    ACETEC Alphapharm Pty Ltd

    TGA: approved Β· NMPA: clinical trials

  3. enalapril + hydrochlorothiazide

    RENITEC PLUS 20/6 Alphapharm Pty Ltd

    TGA: approved

  4. enalapril maleate

    AQUMELDI Amneal Pharma Europe Ltd

    ORAL FDA: approved Β· EMA: approved

    C09AA02
  5. enalaprilat

    ENALAPRILAT

    INJECTION FDA: approved

  6. enarodustat

    ENAROY

    PMDA: approved

  7. enasidenib mesylate

    IDHIFA

    ORAL FDA: approved

  8. enclomifene

    ENCYZIX

    EMA: refused

    G03X
  9. encorafenib

    BRAFTOVI Pierre Fabre Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01EC03
  10. endocrine

    NMPA: clinical trials

  11. endostar

    NMPA: clinical trials

  12. enflurane

    ENFLURANE

    INHALATION FDA: approved

  13. enfortumab

    NMPA: clinical trials

  14. enfortumab vedotin

    PADCEV Astellas Pharma Inc

    EMA: approved Β· TGA: approved

    L01FX13
  15. enfortumab vedotin-ejfv

    PADCEV

    INJECTION FDA: approved

  16. enfuvirtide

    FUZEON

    SUBCUTANEOUS FDA: approved Β· EMA: approved

    J05AX07
  17. enoxacin

    PENETREX

    ORAL FDA: approved

  18. enoxaparin

    NMPA: clinical trials

  19. enoxaparin sodium

    CLEXANE FORTE SAFETY-LOCK Sanofi-aventis Healthcare Pty Ltd

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved

    B01AB05
  20. ensartinib

    NMPA: clinical trials

  21. ensartinib hydrochloride

    ENSACOVE

    ORAL FDA: approved

  22. ensifentrine

    OHTUVAYRE

    INHALATION FDA: approved Β· EMA: application withdrawn

    R03BX
  23. ensitrelvir fumaric acid

    XOCOVA (NOTE 3)

    PMDA: approved

  24. entacapone

    COMTAN Sandoz Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    N04BX02

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources